Medical Technology: B. Braun Invests 60 Million Euros in Plant Expansion
Translated from German, summarized and contextualized by DistantNews.
TLDR
- Medical technology manufacturer B. Braun has significantly expanded its plant for dialysis machines and infusion pumps in Melsungen, Germany.
- The company invested approximately 60 million euros in the expansion, which adds about 70% more space to the production and logistics area.
- The expanded facility aims to enhance healthcare supply in Germany and worldwide, incorporating modern production and digitally networked logistics.
Die Zeit reports on a significant investment by the medical technology company B. Braun in its Melsungen, Germany, facility. The family-owned business has poured around 60 million euros into expanding its production site for dialysis machines and infusion pumps. This expansion adds approximately 70% more space, enhancing both manufacturing capacity and digital logistics. CEO Anna Maria Braun emphasized that this investment is crucial for ensuring the future viability of production and contributing significantly to healthcare supply, both domestically and globally. The newly operational facility, completed after three years of construction, will produce vital equipment for treating kidney diseases, as well as infusion pumps for precise medication delivery in areas like pain and cancer therapy. B. Braun's commitment to modernizing its production and logistics underscores its role as a key player in the healthcare sector. For Germany, such investments signal a commitment to maintaining high-quality manufacturing and technological advancement within the country, reinforcing its position as a hub for medical innovation and production.
By positioning production locally for the future, we are making an important contribution to healthcare in Germany and worldwide
Originally published by Die Zeit in German. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.